This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: ABT AMZN CROX DF TRIP

Stocks in this article: ABT AMZN CROX DF TRIP

Sprint (S) was upgraded at Deutsche Bank to buy from hold. Twelve-month price target is $9.25. Stock has pulled back to an attractive level, Deutsche Bank said.

TripAdvisor (TRIP) was upgraded at RBC to outperform from underperform. Twelve-month price target is $95. Company should begin to see accelerating growth in click-based advertising revenue, RBC said.

Veeco (VECO) was upgraded at Credit Suisse to outperform from neutral. Twelve-month price target is $50. Order outlook is improving, Credit Suisse said.

Stock Comments / EPS Changes

Conagra (CAG) estimates, price target were reduced at Credit Suisse. Shares are now seen reaching $31. Estimates were also cut, following the company's latest profit warning, Credit Suisse said. Neutral rating.

ConAgra Foods (CAG) price target, EPS estimates were cut at Jefferies. All operating segments are under pressure, and management lowered guideance, Jefferies said. Twelve-month price target is $35. Buy rating.

CNO Financial (CNO) price target, EPS estimates were lifted at UBS. Strong fourth-quarter results and closed block LTC reinsurance deal should drive upside, UBS said. Twelve-month price target is now $19. Neutral rating.

Fossil (FOSL) estimates, price target were increased at Sterne Agee. Estimates were boosted through 2015. Company is seeing higher wholesale demand in North America, Sterne Agee said. Twelve-month price target is now $132.

International Exchange (ICE) numbers were increased at BMO Capital. Estimates were boosted through 2015. Company is cutting costs, BMO Capital said. Outperform rating and new 12-month price target of $230.

Eli Lilly (LLY) price target increased at Jefferies. Strong performance in Cymbalta, Humalog, Alimta and Cialis, Jefferies said. Twelve-month price target is $44. Underperform rating.

Sprint (S) price target, EPS estimates were raised at UBS. Tablets were a big driver of subscriber growth in the fourth quarter. Twelve-month price target is $8. Neutral rating.

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,064.28 +10.57 0.06%
S&P 500 2,093.09 +4.32 0.21%
NASDAQ 4,812.4370 +5.5780 0.12%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs